July 2, 2024 15:01

Ken Asada, Senior Research Scientist, Hidenori Machino, Research Scientist, Norio Shinkai, Technical Scientist, Satoshi Takahashi, Research Scientist, Amina Bolatkan, Postdoctoral Researcher, Masaaki Komatsu, Deputy Team Leader and Ryuji Hamamoto, Team Leader of the Cancer Translational Research Team at RIKEN AIP have published a research paper entitled“Mechanism of ERBB2 gene overexpression by the formation of super-enhancer with genomic structural abnormalities in lung adenocarcinoma without clinically actionable genetic alterations” in Molecular Cancer, a peer-reviewed open-access scientific journal.

  • Title: Mechanism of ERBB2 gene overexpression by the formation of super-enhancer with genomic structural abnormalities in lung adenocarcinoma without clinically actionable genetic alterations
  • Authors: Syuzo Kaneko (* Corresponding Author), Ken Takasawa, Ken Asada, Kouya Shiraishi, Noriko Ikawa, Hidenori Machino, Norio Shinkai, Maiko Matsuda, Mari Masuda, Shungo Adachi, Satoshi Takahashi, Kazuma Kobayashi, Nobuji Kouno, Amina Bolatkan, Masaaki Komatsu, Masayoshi Yamada, Mototaka Miyake, Hirokazu Watanabe, Akiko Tateishi, Takaaki Mizuno, Yu Okubo, Masami Mukai, Tatsuya Yoshida, Yukihiro Yoshida, Hidehito Horinouchi, Shun-Ichi Watanabe, Yuichiro Ohe, Yasushi Yatabe, Vassiliki Saloura, Takashi Kohno, Ryuji Hamamoto (* Corresponding Author)

For more information, please see the following URL
Molecular Cancer
National Cancer Center Japan

Related Laboratories

last updated on April 17, 2024 15:58Laboratory